Skye Bioscience, Inc. Quarterly Return On Equity in % from Q3 2013 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Skye Bioscience, Inc. quarterly/annual Return On Equity history and growth rate from Q3 2013 to Q3 2024.
  • Skye Bioscience, Inc. Return On Equity for the quarter ending September 30, 2024 was -37.7 %, a 103% decline year-over-year.
  • Skye Bioscience, Inc. annual Return On Equity for 2023 was 1.16K %, a 46.2% decline from 2022.
  • Skye Bioscience, Inc. annual Return On Equity for 2022 was 2.15K %.
  • Skye Bioscience, Inc. annual Return On Equity for 2021 was -181 %, a 117% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -37.7 -1.28K -103% Jul 1, 2024 Sep 30, 2024
Q2 2024 -112 -563 -125% Apr 1, 2024 Jun 30, 2024
Q1 2024 -212 -972 -128% Jan 1, 2024 Mar 31, 2024
Q4 2023 1.16K -994 -46.2% Oct 1, 2023 Dec 31, 2023
Q3 2023 1.24K +2.16K Jul 1, 2023 Sep 30, 2023
Q2 2023 452 +709 Apr 1, 2023 Jun 30, 2023
Q1 2023 760 +954 Jan 1, 2023 Mar 31, 2023
Q4 2022 2.15K +2.33K Oct 1, 2022 Dec 31, 2022
Q3 2022 -922 -699 -313% Jul 1, 2022 Sep 30, 2022
Q2 2022 -257 +139 +35.1% Apr 1, 2022 Jun 30, 2022
Q1 2022 -194 +1.32K +87.2% Jan 1, 2022 Mar 31, 2022
Q4 2021 -181 -1.23K -117% Oct 1, 2021 Dec 31, 2021
Q3 2021 -223 -258 -747% Jul 1, 2021 Sep 30, 2021
Q2 2021 -396 -470 -632% Apr 1, 2021 Jun 30, 2021
Q1 2021 -1.51K -1.33K -718% Jan 1, 2021 Mar 31, 2021
Q4 2020 1.05K +1.06K Oct 1, 2020 Dec 31, 2020
Q3 2020 34.5 -21.6 -38.5% Jul 1, 2020 Sep 30, 2020
Q2 2020 74.4 +30.3 +68.8% Apr 1, 2020 Jun 30, 2020
Q1 2020 -185 -351 -211% Jan 1, 2020 Mar 31, 2020
Q4 2019 -7.6 -201 -104% Oct 1, 2019 Dec 31, 2019
Q3 2019 56.1 -140 -71.4% Jul 1, 2019 Sep 30, 2019
Q2 2019 44.1 -186 -80.9% Apr 1, 2019 Jun 30, 2019
Q1 2019 167 -92.4 -35.7% Jan 1, 2019 Mar 31, 2019
Q4 2018 193 +95.1 +96.9% Oct 1, 2018 Dec 31, 2018
Q3 2018 196 +76.2 +63.4% Jul 1, 2018 Sep 30, 2018
Q2 2018 230 +84.5 +57.8% Apr 1, 2018 Jun 30, 2018
Q1 2018 259 +146 +128% Jan 1, 2018 Mar 31, 2018
Q4 2017 98.2 -38.8 -28.3% Oct 1, 2017 Dec 31, 2017
Q3 2017 120 -31.5 -20.8% Jul 1, 2017 Sep 30, 2017
Q2 2017 146 -72.3 -33.1% Apr 1, 2017 Jun 30, 2017
Q1 2017 113 -363 -76.2% Jan 1, 2017 Mar 31, 2017
Q4 2016 137 -584 -81% Oct 1, 2016 Dec 31, 2016
Q3 2016 152 -890 -85.5% Jul 1, 2016 Sep 30, 2016
Q2 2016 218 -2.3K -91.3% Apr 1, 2016 Jun 30, 2016
Q1 2016 476 +22.5K Jan 1, 2016 Mar 31, 2016
Q4 2015 721 +3.01K Oct 1, 2015 Dec 31, 2015
Q3 2015 1.04K +1.59K Jul 1, 2015 Sep 30, 2015
Q2 2015 2.52K +3.95K Apr 1, 2015 Jun 30, 2015
Q1 2015 -22.1K -21.5K -3688% Jan 1, 2015 Mar 31, 2015
Q4 2014 -2.29K -28.2K Oct 1, 2014 Dec 31, 2014
Q3 2014 -549 -5.91K -110% Jul 1, 2014 Sep 30, 2014
Q2 2014 -1.43K Apr 1, 2014 Jun 30, 2014
Q1 2014 -582 Jan 1, 2014 Mar 31, 2014
Q4 2013 25.9K* Nov 1, 2013 Jan 31, 2014
Q3 2013 5.37K Jul 1, 2013 Sep 30, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.